1. Home
  2. Programs
  3. NeuroFrontiers

Studying Cortical Lesions in MS: Future Research Directions

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
  • Overview

    Current research suggests that therapies like ocrelizumab may impact cortical lesions in multiple sclerosis (MS) patients, but more studies are needed to confirm their effects and clinical significance. Here to share his insights on where research focusing on cortical lesions in MS might be headed is Dr. Michael G. Dwyer, Associate Professor of Neurology and Biomedical Informatics at the University at Buffalo.

Recommended
Details
Presenters
  • Overview

    Current research suggests that therapies like ocrelizumab may impact cortical lesions in multiple sclerosis (MS) patients, but more studies are needed to confirm their effects and clinical significance. Here to share his insights on where research focusing on cortical lesions in MS might be headed is Dr. Michael G. Dwyer, Associate Professor of Neurology and Biomedical Informatics at the University at Buffalo.

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free